Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
BROKEN-SWEDEHEART
NCT04666454Phase 4Recruiting
- Sponsor
- Region Västra Götaland
- Start
- Dec 2020
- Primary completion
- Dec 2028
- Modality
- Orthosteric Ligands, Metabolically Activated Prodrugs
- Countries
- 3
01
Overview
A Phase 4 trial of adenosine, dipyridamole, apixaban in takotsubo syndrome (TTS), sponsored by Region Västra Götaland. Started Dec 2020; status: recruiting.
02
Drugs
adenosinedipyridamoleapixaban
03
Conditions
takotsubo syndrome (TTS)
Beyond the preview
Go deeper on NCT04666454.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04666454.